Article: Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19.
Journal of drugs in dermatology : JDD
2024 Volume 23, Issue 2, Page(s) e64–e66
Abstract: Background: During the global COVID-19 pandemic, dermatologists increasingly adopted teledermatology to facilitate patient care.: Objective: To identify differences in teledermatology platform usage and functionality among dermatologists as a means ... ...
| Abstract | Background: During the global COVID-19 pandemic, dermatologists increasingly adopted teledermatology to facilitate patient care. Objective: To identify differences in teledermatology platform usage and functionality among dermatologists as a means of understanding the potential effect on virtual healthcare access. Methods: Results from a 2021 cross-sectional pre-validated survey distributed to actively practicing United States dermatologists were analyzed based on timepoint when teledermatology was adopted relative to COVID-19, previous/currently used platforms, self-reported platform functionality, and barriers to teledermatology implementation. Analysis was performed using chi-square and odds ratios (OR) with 95% confidence intervals (95% CI) for categorical data and single-factor analysis of variance (ANOVA) with post-hoc Tukey-Kramer for continuous data. P<.05 was considered significant. Results: Early adopters (EAs) trialed significantly more (2.3 vs 1.9, P=0.02) platforms than (post) COVID adopters (CAs) before choosing their current platform. More EAs reported using platforms capable of uploading images (P=.002), required a mobile application (P=.006), and allowed staff to join patient encounters (P<.001). While poor image quality was the most cited barrier to implementation, CAs and non-adaptors (NAs) were materially more likely to cite it as their largest barrier to teledermatology. Limitations: The retrospective nature of the study and potential response bias. Conclusion: Dermatologists' use of teledermatology materially correlates with their teledermatology-adoption timepoint, and future usage may be materially impacted by the end of the COVID-19 public health emergency. Future studies should aim at how implementation and barriers to teledermatology usage may impact access to care. J Drugs Dermatol. 2024;23(2): doi:10.36849/JDD.7819e. |
|---|---|
| MeSH term(s) | Humans ; United States/epidemiology ; Dermatology/methods ; Cross-Sectional Studies ; COVID-19/epidemiology ; Telemedicine ; Retrospective Studies ; Pandemics ; Dermatologists |
| Language | English |
| Publishing date | 2024-02-05 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 2145090-0 |
| ISSN | 1545-9616 |
| ISSN | 1545-9616 |
| DOI | 10.36849/JDD.7819 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 5931: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.